Nordic Capital acquired Ober Scharrer Gruppe, Germany’s largest provider for treatments for major causes of blindness and visual impairment as well as non-invasive treatments and diagnosis of eye disorders, from Palamon Capital. Financial terms were not disclosed. “Nordic Capital has followed this sector for several years, observing how OSG has continued to build its strong position and reputation for delivering medical excellence. Nordic Capital looks forward to investing in and supporting OSG’s further development and growth in its field of expertise where we see a strong demand for specialised, high quality centres to provide treatments," says Joakim Lundvall, Partner at the Advisor to the Nordic Capital Funds.